Correction to: Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment‑Refractory Nontuberculous Mycobacterial Lung Disease (European Journal of Drug Metabolism and Pharmacokinetics, (2021), 46, 2, (277-287), 10.1007/s13318-020-00669-7)

Christopher M. Rubino, Nikolas J. Onufrak, Jakko van Ingen, David E. Griffith, Sujata M. Bhavnani, Dayton W. Yuen, Kevin C. Mange, Kevin L. Winthrop

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Correction to: Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment‑Refractory Nontuberculous Mycobacterial Lung Disease (European Journal of Drug Metabolism and Pharmacokinetics, (2021), 46, 2, (277-287), 10.1007/s13318-020-00669-7)'. Together they form a unique fingerprint.

Medicine & Life Sciences